Clairvoyant Therapeutics

BiotechnologySeedVancouver, Canadaclairvoyantrx.com

Latest round

Seed

Last raised

Nov 2021

Total raised

$2.4M

Investors

3

About Clairvoyant Therapeutics

Based in Vancouver, Canada, and founded in 2021 by its CEO, Damian Kettlewell, and co-founder, Thomas Digby, Clairvoyant Therapeutics, Inc. is a biotechnology company that offers psilocybin drug therapy. In November 2021, Clairvoyant Therapeutics Inc.'s product line offers psilocybin drug therapy for the treatment of mental health challenges. It combines the pharmacological effects of psilocybin, a psychoactive substance, with psychological support. The company's research and development team also designs and operates clinical trials. Clairvoyant Therapeutics Inc. The company is also planning to have clinical sites in the EU and Canada.

Who invested in Clairvoyant Therapeutics

3 investors across 1 round

See all investors in Clairvoyant Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Nov 30, 2021

    Amount

    $2.4M

    Investors

    Locked

Questions about Clairvoyant Therapeutics

Who invested in Clairvoyant Therapeutics?

Clairvoyant Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Clairvoyant Therapeutics raised?

Clairvoyant Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Clairvoyant Therapeutics last raise money?

Clairvoyant Therapeutics's most recent round on record is a Seed, in Nov 2021.

What does Clairvoyant Therapeutics do?

Based in Vancouver, Canada, and founded in 2021 by its CEO, Damian Kettlewell, and co-founder, Thomas Digby, Clairvoyant Therapeutics, Inc.

Where is Clairvoyant Therapeutics headquartered?

Clairvoyant Therapeutics is headquartered in Vancouver, Canada.

Which VCs invest in companies like Clairvoyant Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Clairvoyant Therapeutics's stage. Their profiles are linked below.

Raising like Clairvoyant Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.